Design and rationale of a multicenter defeat alcoholic steatohepatitis trial: (DASH) randomized clinical trial to treat alcohol-associated hepatitis

BACKGROUND/AIMS: Despite high mortality of alcohol-associated hepatitis, there has been limited advancement in treatment strategies. Defeat Alcoholic Steatohepatitis (DASH) is a multicenter, randomized, double-blind controlled trial whose primary objective was to evaluate the safety and efficacy of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Contemp Clin Trials
Hlavní autoři: Dasarathy, Srinivasan, Mitchell, Mack C., Barton, Bruce, McClain, Craig J., Szabo, Gyongyi, Nagy, Laura E., Radaeva, Svetlana, McCullough, Arthur J.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7494528/
https://ncbi.nlm.nih.gov/pubmed/32739495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2020.106094
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky